Description

  • Product name

    Semaphorin 3F peptide
  • Animal free

    No
  • Nature

    Synthetic

Specifications

Our Abpromise guarantee covers the use of ab216125 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Blocking

  • Form

    Lyophilised
  • Additional notes

    This is the blocking peptide for ab39956.

    Reconstitution Notes:

    -First try to dissolve a small amount of peptide in either water or buffer. The more charged residues on a peptide, the more soluble it is in aqueous solutions.

    - If the peptide doesn’t dissolve try an organic solvent e.g. DMSO, then dilute using water or buffer.
    - Consider that any solvent used must be compatible with your assay. If a peptide does not dissolve and you need to recover it, lyophilise to remove the solvent.
    - Gentle warming and sonication can effectively aid peptide solubilisation. If the solution is cloudy or has gelled the peptide may be in suspension rather than solubilised.
    - Peptides containing cysteine are easily oxidised, so should be prepared in solution just prior to use.

    - First try to dissolve a small amount of peptide in either water or buffer. The more charged residues on a peptide, the more soluble it is in aqueous solutions.
    - If the peptide doesn’t dissolve try an organic solvent e.g. DMSO, then dilute using water or buffer.
    - Consider that any solvent used must be compatible with your assay. If a peptide does not dissolve and you need to recover it, lyophilise to remove the solvent.
    - Gentle warming and sonication can effectively aid peptide solubilisation. If the solution is cloudy or has gelled the peptide may be in suspension rather than solubilised.
    - Peptides containing cysteine are easily oxidised, so should be prepared in solution just prior to use.

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Store at -20°C.

General Info

  • Alternative names

    • SEM3F_HUMAN
    • sema domain immunoglobulin domain Ig short basic domain secreted 3F
    • sema domain immunoglobulin domain Ig short basic domain secreted semaphorin 3F
    • Sema III/F
    • Sema IV
    • SEMA-IV
    • SEMA3F
    • SEMA4
    • SemaIII/F
    • SemaIV
    • SEMAK
    • Semaphorin IV
    • Semaphorin-3F
    • Semaphorin3F
    • SemaphorinIV
    see all
  • Function

    May play a role in cell motility and cell adhesion.
  • Tissue specificity

    Expressed abundantly but differentially in a variety of neural and nonneural tissues. There is high expression in mammary gland, kidney, fetal brain, and lung and lower expression in heart and liver.
  • Sequence similarities

    Belongs to the semaphorin family.
    Contains 1 Ig-like C2-type (immunoglobulin-like) domain.
    Contains 1 Sema domain.
  • Developmental stage

    Detected as early as embryonic day 10.
  • Cellular localization

    Secreted.
  • Information by UniProt

References

ab216125 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab216125.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up